Published On Oct 18, 2021
HIH, Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19
https://www.covid19treatmentguideline...
https://www.cms.gov/medicare/covid-19...
FDA live
https://www.fda.gov/consumers/consume...
NIH live
https://www.covid19treatmentguideline...
Adults: Dosing Regimens
The dose most commonly used in clinical trials is IVM 0.2–0.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days.
Adverse events
Generally well tolerated
Dizziness
Pruritis
GI effects (e.g., nausea, diarrhea)
Neurological AEs have been reported when IVM has been used to treat parasitic diseases,
but it is not clear whether these AEs were caused by IVM or the underlying conditions.
Comments and links to clinical trials
Generally given on an empty stomach with water; however, administering IVM with food increases its bioavailability.
A list of clinical trials is available here: Ivermectin
Russia
Deaths,
https://coronavirus.jhu.edu/region/ru...
https://www.washingtonpost.com/world/...
Independent demographer Alexey Raksha
Using data from Rosstat, Russia’s statistical agency
https://eng.rosstat.gov.ru/folder/11335
Excess mortality, around 750,000
https://www.themoscowtimes.com/2021/1...
Excess mortality, around 660,000
Tracking cases around the world
Officials manipulated statistics and underplayed the crisis
China, Turkey
https://www.washingtonpost.com/world/...
Alexei Kouprianov, independent analyst and biologist
The data for [Russia] is absolutely unreliable
Recently ex St. Petersburg campus of the Higher School of Economics (September 2020)
Handling of the pandemic, largely left to the regions
Regional officials conceal problems, fear of losing their posts
Therefore critics, even analytical experts, are sidelined
Iceland restricts Moderna
https://www.landlaeknir.is/um-embaett...
https://www.icelandreview.com/society...
https://www.icelandreview.com/news/mo...
Chief Epidemiologist, Þórólfur Guðnason
Moderna, only be used for booster shots in 60+
Unpublished data from the Nordic countries indicate that the risk of cardiac inflammation after vaccination against COVID-19 is much higher among 18 to 39-year-olds if the Moderna vaccine is used than after vaccination with the Pfizer vaccine
Cardiac inflammation after vaccination is much less common among older demographics
In 12 to 17-year-olds, lack of European data
Under 60 who have received a single shot of Modern, to complete their vaccination with Pfizer
Men 18-39 are not recommended to accept the Moderna COVID-19 vaccine
Iceland data, vast majority of vaccination side effects emerge shortly after vaccination